Literature DB >> 546786

Polymorphonuclear leukocyte adherence to nylon: effect of oral corticosteroids.

J McGillen, J Phair.   

Abstract

The effect of orally administered glucocorticoids on polymorphonuclear leukocyte adherence was studied by using the nylon fiber adherence assay. Inhibition of adherence 4 h after administration of the agent was confirmed, and in addition, augmentation of adherence was noted 24 h after ingestion of prednisone. Crossover studies revealed inhibition and augmentation to be cell associated as well as plasma mediated. Suspension of washed, dextran-sedimented polymorphonuclear leukocytes, harvested 4 h after prednisone ingestion in base-line or 24-h plasma failed to reverse inhibition of adherence. Adherence of 24-h polymorphonuclear leukocytes was augmented when suspended in all test plasmas. Plasma-mediated effects were demonstrated by inhibition of base-line adherence of polymorphonuclear leukocytes suspended in 4-h plasma and augmentation of adherence of cells in 24-h plasma. Plasma-mediated effects were reversible by washing.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 546786      PMCID: PMC414650          DOI: 10.1128/iai.26.2.542-546.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects.

Authors:  J W ATHENS; O P HAAB; S O RAAB; A M MAUER; H ASHENBRUCKER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1961-06       Impact factor: 14.808

2.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

Authors:  P R Craddock; D Hammerschmidt; J G White; A P Dalmosso; H S Jacob
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  The effect of anti-inflammatory agents and inflammation on granulocyte adherence. Evidence for regulation by plasma factors.

Authors:  R R MacGregor
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

4.  Mechanism of anti-complementary activity of corticosteroids in vivo: possible relevance in endotoxin shock.

Authors:  J T O'Flaherty; P R Craddock; H S Jacob
Journal:  Proc Soc Exp Biol Med       Date:  1977-02

5.  Comparative adherence of granulocytes to endothelial monolayers and nylon fiber.

Authors:  R R MacGregor; E J Macarak; N A Kefalides
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

6.  Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis.

Authors:  R A Clark; J I Gallin; A S Fauci
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

7.  Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone.

Authors:  D C Dale; A S Fauci; I V Guerry D; S M Wolff
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

8.  Inhibition of neutrophil Fc receptor function by cotricosteroids.

Authors:  M S Klempner; J I Gallin
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

9.  Separation and functional characterization of human neutrophil subpopulations.

Authors:  M S Klempner; J I Gallin
Journal:  Blood       Date:  1978-04       Impact factor: 22.113

10.  In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresis.

Authors:  J Fehr; H S Jacob
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  2 in total

1.  Effects of in vivo dexamethasone administration on in vitro bovine polymorphonuclear leukocyte function.

Authors:  J A Roth; M L Kaeberle
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

2.  The effect of in vitro and in vivo dexamethasone on human neutrophil function.

Authors:  D A Lomas; M Ip; A Chamba; R A Stockley
Journal:  Agents Actions       Date:  1991-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.